Tumor News and Research

RSS

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Human Genome Sciences has begun dosing patients in a Phase 1 clinical trial of HGS-TR2J, a novel agonistic human monoclonal antibody to TRAIL Receptor 2, in patients with advanced solid malignancies.

25 Aug 2004

Researchers using light to control genes and better understand the role of certain genes in embryonic development

As our understanding of biology increases, the tools of research become almost as important as the researchers wielding them. Currently, one of the major obstacles to research is actually getting inside of cells and tissue to see what is going on as it happens.

25 Aug 2004

Researchers have identified multiple changes in the gene-expression patterns of cells involved with tumor progression in liver cancer patients

Virginia Commonwealth University researchers have identified multiple changes in the gene-expression patterns of cells involved with tumor progression in liver cancer patients and in those with cirrhosis, which may help scientists predict a person’s risk of developing primary liver cancer.

25 Aug 2004

Scientists have uncovered a key driver behind the progression of prostate cancer

Scientists at Fred Hutchinson Cancer Research Center have uncovered a key driver behind the progression of prostate cancer, a discovery that the researchers believe could spawn new treatments to prevent the cancer's spread and extend survival.

23 Aug 2004

Powerful new cancer-fighting property of Herceptin

For many patients with advanced breast cancer, the cancer drug Herceptin (trastuzumab) has offered new hope when traditional cancer drugs failed to work, shrinking tumors and sending some patients into remission.

23 Aug 2004

Exposure to simian virus 40 (SV40) is not associated with cancer in humans

Two upcoming studies by scientists at the National Cancer Institute (NCI), provide further evidence that exposure to simian virus 40 (SV40) is not associated with cancer in humans.

23 Aug 2004

African-American women are less likely to be treated with breast reconstruction after mastectomy than women of other races

According to a new study published August 23, 2004 in the online edition of CANCER, a peer-reviewed journal of the American Cancer Society, African-American women had significantly lower immediate breast reconstruction rates compared to Caucasian, Asian, and Hispanic women. The abstract of this article will be freely accessible via the CANCER Newsroom.

23 Aug 2004

Dual-action compound shows promise in killing prostate cancer cells

Ohio State University researchers are working on developing a multi-purpose cancer drug that might one day scale back the number of medications some cancer patients need to take.

22 Aug 2004

Test for identifying which cases of prostate cancer will become life threatening

Karin Drotschmann, Ph.D., a researcher at Wake Forest University Baptist Medical Center, has won the “New Investigator Award” from the Department of Defense, Prostate Cancer Research Program, for her work to develop a test for identifying which cases of prostate cancer will become life threatening.

20 Aug 2004

Scientists have developed the first mouse model Werner’s syndrome

Scientists have developed the first mouse model of a rare disease in which people age rapidly and start developing cancers and other diseases associated with the elderly when they are only about 30 years old.

20 Aug 2004

Limb-sparing technique called rotationplasty helps very young children with bone cancer

The current issue of New England Journal of Medicine illustrates a case of a five-year-old girl with Ewing’s sarcoma, a cancerous tumor, behind her left knee. Surgeons at The Children’s Hospital of Philadelphia used a limb-sparing technique called rotationplasty to remove the diseased portion of bone, turn the shortened portion of the leg bone in a half-circle and reattach it, with the ankle joint functioning as a knee.

18 Aug 2004

More tumour cells in the blood leads to quicker deterioration in women with breast cancer

A new study of women with advanced breast cancer who have more tumor cells circulating in their blood deterioate and die quicker than women with fewer of these cells, according to the researchers from the University of Michigan Comprehensive Cancer Center and other cancer centers throughout the country.

18 Aug 2004

Embryonic stem cell therapy show benefits in rebuilding damaged heart

Despite improvements in earlier diagnosis and treatment, cardiovascular disease is far and away the leading cause of death in the U.S. and the world.

18 Aug 2004

FDA fast tracks temsirolimus, first-line treatment of poor-prognosis patients with advanced renal cell carcinoma

Wyeth Pharmaceuticals has announced that the U.S. Food and Drug Administration has granted a new "fast track" designation for temsirolimus (CCI-779), an investigational mTOR kinase inhibitor, in the first-line treatment of poor-prognosis patients with advanced renal cell carcinoma (RCC).

18 Aug 2004

New colon cancer guidelines

The American Society of Clinical Oncology has developed a set of recommendations to address whether patients who have had successful surgery for Stage II colon cancer should be offered adjuvant chemotherapy in routine clinical practice.

17 Aug 2004

Immunotherapy and chemotherapy combined, slows tumor progression and extends survival of patients with glioblastoma multiforme

Researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have found that the combination of immunotherapy and chemotherapy significantly slowed tumor progression and extended survival of patients with glioblastoma multiforme (GBM).

17 Aug 2004

Novel pharmacological target for cannabinoid-based therapies

Cannabinoids, the active ingredients in marijuana, restrict the sprouting of blood vessels to brain tumors by inhibiting the expression of genes needed for the production of vascular endothelial growth factor (VEGF).

15 Aug 2004

Receptor for estrogen in ovarian cells has been shown to suppress tumor growth

An important receptor for estrogen in ovarian cells has been shown to suppress tumor growth, according to a new study published in the August 15 issue of the journal Cancer Research.

15 Aug 2004

Genentech announces FDA approval of Avastin manufacturing

Genentech has announced that the U.S. Food and Drug Administration approved the supplemental Biologics License Application (sBLA) for the manufacturing of Avastin™ (bevacizumab) bulk drug substance at the company's facility in Vacaville, California.

11 Aug 2004

Advances in biomedical imaging could lead to more sensitive screening tests for cancer-fighting drugs

Advances in biomedical imaging are allowing UC Davis researchers to use mice more effectively to study cancers comparable to human disease. The system can distinguish different stages of cancer and could lead to more sensitive screening tests for cancer-fighting drugs.

9 Aug 2004

Tumor News and Research

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Researchers using light to control genes and better understand the role of certain genes in embryonic development

Researchers have identified multiple changes in the gene-expression patterns of cells involved with tumor progression in liver cancer patients

Scientists have uncovered a key driver behind the progression of prostate cancer

Powerful new cancer-fighting property of Herceptin

Exposure to simian virus 40 (SV40) is not associated with cancer in humans

African-American women are less likely to be treated with breast reconstruction after mastectomy than women of other races

Dual-action compound shows promise in killing prostate cancer cells

Test for identifying which cases of prostate cancer will become life threatening

Scientists have developed the first mouse model Werner’s syndrome

Limb-sparing technique called rotationplasty helps very young children with bone cancer

More tumour cells in the blood leads to quicker deterioration in women with breast cancer

Embryonic stem cell therapy show benefits in rebuilding damaged heart

FDA fast tracks temsirolimus, first-line treatment of poor-prognosis patients with advanced renal cell carcinoma

New colon cancer guidelines

Immunotherapy and chemotherapy combined, slows tumor progression and extends survival of patients with glioblastoma multiforme

Novel pharmacological target for cannabinoid-based therapies

Receptor for estrogen in ovarian cells has been shown to suppress tumor growth

Genentech announces FDA approval of Avastin manufacturing

Advances in biomedical imaging could lead to more sensitive screening tests for cancer-fighting drugs

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News